1. Cooper, LT. Giant cell myocarditis in children. Prog Pediatr Cardiol. 2007; 24(1):47–49.
Google Scholar | Crossref | Medline2. Saltykow, S . Über diffuse myokarditis. Virchows Arch Pathol Anat Physiol Klin Med. 1905; 182:1–39.
Google Scholar | Crossref3. Trachtenberg, BH, Hare, JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017; 121(7):803–818.
Google Scholar | Crossref | Medline4. Gursu, HA, Cetin, II, Azak, E, et al. The assessment of treatment outcomes in patients with acute viral myocarditis by speckle tracking and tissue Doppler methods. Echocardiography. 2019; 36(9):1666–1674.
Google Scholar | Crossref | Medline5. Laufs, H, Nigrovic, PA, Schneider, LC, et al. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc. 2002; 77(1):92–96.
Google Scholar | Crossref | Medline6. Das, BB, Recto, M, Johnsrude, C. Cardiac transplantation for pediatric giant cell myocarditis. J Heart Lung Transplant. 2006; 25(4):474–478.
Google Scholar | Crossref | Medline7. Kociol, RD, Cooper, LT, Fang, JC, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020; 141(6):e69–e92.
Google Scholar | Crossref | Medline8. Vaideeswar, P, Cooper, LT. Giant cell myocarditis: clinical and pathological disease characteristics in an Indian population. Cardiovasc Pathol. 2013; 22(1):70–74.
Google Scholar | Crossref | Medline9. Cooper, LT, ElAmm, C. Giant cell myocarditis. Diagnosis and treatment. Herz. 2012; 37(6):632–636.
Google Scholar | Crossref | Medline10. Okura, Y, Dec, GW, Hare, JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003; 41(2):322–328.
Google Scholar | Crossref | Medline | ISI11. Cooper, LT, Berry, GJ, Shabetai, R. Idiopathic giant-cell myocarditis: natural history and treatment. N Engl J Med. 1997; 336(26):1860–1866.
Google Scholar | Crossref | Medline12. Steger, CM, Höfer, D, Antretter, H. Giant cell and granulomatous myocarditis necessitating cardiac transplantation: clinical, gross, and histopathological findings. Eur Surg. 2014; 46(5):209–215.
Google Scholar | Crossref13. Xu, J, Brooks, EG. Giant cell myocarditis: a brief review. Arch Pathol Lab Med. 2016; 140(12):1429–1434.
Google Scholar | Crossref | Medline14. Kandolin, R, Lehtonen, J, Salmenkivi, K, Räisänen-Sokolowski, A, Lommi, J, Kupari, M. Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression. Circ Heart Fail. 2013; 6(1):15–22.
Google Scholar | Crossref | Medline15. Shields, RC, Tazelaar, HD, Berry, GJ, Cooper, LT The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis. J Card Fail. 2002; 8(2):74–78.
Google Scholar | Crossref | Medline16. Blauwet, LA, Cooper, LT. Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev. 2013; 18(6):733–746.
Google Scholar | Crossref | Medline17. Villa, A, Notarangelo, LD, Roifman, CM. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol. 2008; 122(6):1082–1086
Google Scholar | Crossref | Medline18. Arbustini E, Narula N, Giuliani L, Di Toro A. Genetic Basis of Myocarditis: Myth or Reality?. Myocarditis. 2020; 45–89.
Google Scholar19. Zago, CA, Jacob, CM, de Albuquerque Diniz, EM, et al. Autoimmune manifestations in SCID due to IL7R mutations: Omenn syndrome and cytopenias. Hum Immunol. 2014; 75(7):662–666.
Google Scholar | Crossref | Medline20. Brückmann, C, Lindner, W, Roos, R, et al. Severe pulmonary vascular occlusive disease following bone marrow transplantation in Omenn syndrome. Eur J Pediatr. 1991; 150(4):242–245.
Google Scholar | Crossref | Medline21. Navabi, B, Upton, JE. Primary immunodeficiencies associated with eosinophilia. Allergy Asthma Clin Immunol. 2016; 12:27.
Google Scholar | Crossref | Medline22. Bracamonte-Baran, W, Čiháková, D. Cardiac autoimmunity: myocarditis. Adv Exp Med Biol. 2017; 1003:187–221.
Google Scholar | Crossref | Medline23. Ekström, K, Lehtonen, J, Kandolin, R, Räisänen-Sokolowski, A, Salmenkivi, K, Kupari, M. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail. 2016; 18(12):1452–1458.
Google Scholar | Crossref | Medline24. Ong, S, Ligons, DL, Barin, JG, et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol. 2015; 185(3):847–861.
Google Scholar | Crossref | Medline25. Tschöpe, C, Ammirati, E, Bozkurt, B, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021; 18(3):169–193.
Google Scholar | Crossref | Medline26. Litovsky, SH, Burke, AP, Virmani, R. Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol. 1996; 9(12):1126–1134.
Google Scholar | Medline